ArticleMetabolic brain disease2025
Simple scoring model for predicting overt hepatic encephalopathy in geriatric cirrhosis: A multicenter retrospective cohort study.
Article in Metabolic brain disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Covert hepatic encephalopathy as a multi-organ syndrome: the gut-liver-muscle-brain axis, diagnosis, treatment, and multidisciplinary care.Journal of gastroenterology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Identifying the risk of overt hepatic encephalopathy (OHE) in geriatric patients with cirrhosis remains challenging. This study aimed to investigate the independent factors for OHE development in geriatric cirrhosis and to establish a simple scoring model to identify individuals at risk for OHE. We conducted a retrospective review of geriatric patients with cirrhosis aged ≥ 80 years who were admitted between April 2006 and November 2022. Baseline parameters were assessed at the time of admission, and factors associated with OHE development were examined using Fine-Gray proportional hazards regression analysis, with mortality as a competing risk. Based on the factors associated with OHE development, a simple hepatic encephalopathy (sHE) score was calculated, and its efficacy was subsequently verified. Of the 270 patients analyzed, the median age was 83 years, and 63% were male. During a median follow-up of 1.8 years, 41 (15%) patients developed OHE and 120 (44%) patients died. Multivariable analysis revealed that serum albumin (sub-distribution hazard ratio [SHR], 0.51; 95% confidence interval [CI], 0.27-0.98; p = 0.042) and ammonia (SHR, 1.01; 95% CI, 1.00-1.02; p = 0.006) levels were independent factors for OHE development in geriatric cirrhosis. Based on the sHE score, the high-risk and intermediate-risk groups exhibited a high incidence of OHE, whereas those in the low-risk group rarely developed OHE. Serum albumin and ammonia levels were identified as independent risk factors for the development of OHE in geriatric cirrhosis. The sHE score was useful for stratifying the risk of OHE in the geriatric population.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.